Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genasense + Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT00017602Phase 3Completed
- Sponsor
- Genta Incorporated
- Start
- Dec 2000
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 3 trial of oblimersen in multiple myeloma (MM), sponsored by Genta Incorporated. Started Dec 2000; status: completed.
02
Drugs
oblimersen
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00017602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017602.